Correlation Between Live Ventures and Tscan Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Live Ventures and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Live Ventures and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Live Ventures and Tscan Therapeutics, you can compare the effects of market volatilities on Live Ventures and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Live Ventures with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Live Ventures and Tscan Therapeutics.

Diversification Opportunities for Live Ventures and Tscan Therapeutics

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Live and Tscan is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Live Ventures and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Live Ventures is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Live Ventures are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Live Ventures i.e., Live Ventures and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between Live Ventures and Tscan Therapeutics

Given the investment horizon of 90 days Live Ventures is expected to generate 1.01 times more return on investment than Tscan Therapeutics. However, Live Ventures is 1.01 times more volatile than Tscan Therapeutics. It trades about -0.19 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.25 per unit of risk. If you would invest  944.00  in Live Ventures on December 1, 2024 and sell it today you would lose (140.00) from holding Live Ventures or give up 14.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Live Ventures  vs.  Tscan Therapeutics

 Performance 
       Timeline  
Live Ventures 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Live Ventures has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Tscan Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Live Ventures and Tscan Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Live Ventures and Tscan Therapeutics

The main advantage of trading using opposite Live Ventures and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Live Ventures position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.
The idea behind Live Ventures and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals